RO7283420
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7283420, covering 2024-06-03 to 2024-06-03. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420. [Phase 1]